We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

47 hedge funds and large institutions have $8.49M invested in Applied Genetic Technologies Corporation in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 19 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,300% more call options, than puts

Call options by funds: $72K | Put options by funds: $3K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

11% less funds holding

Funds holding: 5347 (-6)

42% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 12

47% less capital invested

Capital invested by funds: $16.2M → $8.49M (-$7.69M)

74% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 19

Holders
47
Holders Change
-6
Holders Change %
-11.32%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
5
Reduced
19
Closed
12
Calls
$72K
Puts
$3K
Net Calls
+$69K
Net Calls Change
+$540K
Name Holding Trade Value Shares
Change
Change in
Stake
ACM
51
Aquatic Capital Management
Illinois
-$2K -1,700 Closed
Federated Hermes
52
Federated Hermes
Pennsylvania
-$1K -122 Closed
SWA
53
SOA Wealth Advisors
New York
+$134 +150 New
WWMSC
54
Wagner Wealth Management (South Carolina)
South Carolina
+$147 +165 New

AGTC Hedge Fund Activity: Q2 2022 in Review

47 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q2 2022, worth a combined $8.49M — down 47% from $16.2M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of AGTC and 7 opened new positions — a net loss of 5 holders — while 19 trimmed existing stakes and 5 added.

The largest buyer was Renaissance Technologies, adding an estimated $167K. The largest seller was Cantor Fitzgerald, cutting an estimated $2.09M.

  • 47 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q2 2022, down from 53 in Q1 2022.
  • Funds reported $8.49M of Applied Genetic Technologies Corporation stock for Q2 2022, down 47% quarter-over-quarter.
  • 7 funds opened new Applied Genetic Technologies Corporation positions in Q2 2022 and 12 closed out, a net change of -5 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q2 2022 was Renaissance Technologies, an estimated $167K added.
  • The largest Applied Genetic Technologies Corporation seller in Q2 2022 was Cantor Fitzgerald, an estimated $2.09M sold.

Based on aggregated 13F filings for Q2 2022.